22nd Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Overview

The 22nd Annual International Symposium on Melanoma and Other Cutaneous Malignancies^® is a single-day, live, in-person educational conference designed to examine current and emerging treatments in melanoma, basal cell carcinoma, squamous cell carcinoma, and other skin-related cancers. This engaging program, with insights from world-renowned experts, will bring you up-to-date on the evolving standards of care in melanoma and other cutaneous malignancies.

The discussion-based nature of this symposium will provide updates for physicians who treat skin cancers. With unmatched access to leading international experts in the field, this reimagined roundtable format will foster didactic dialogue and enable participants to apply the latest research to improve their clinical practice. Dynamic and interactive case-based panel discussions will allow experts to debate key questions in the field and provide evidence-based answers to attendees to enhance their care of patients with melanoma and other cutaneous malignancies.

Learning Objectives

• Determine the role of biomarkers in developing personalized treatment plans for patients with skin cancers
• Assess recent evidence from clinical trials focusing on current and emerging novel treatment approaches for melanoma and other skin tumor
• Devise management protocols aligned with best practices for treating melanomas, squamous cell carcinoma, basal cell carcinoma, and other skin malignancies
• Develop strategies to identify and address complications in the treatment of skin cancers, including brain metastases and treatment-related toxicities

Program Co-Chairs

Omid Hamid, MD & Sapna Patel, MD

To view full profile, click on the Program Co-Chairs tab above.

In remembrance of Jeffrey S. Weber, MD, PhD. His innovative work has profoundly shaped the field, bringing hope to countless patients and advancing clinical practice. We honor his legacy and celebrate his numerous contributions, which will continue to inspire and guide future generations of oncologists.